 | • レポートコード：D0GIR-08569 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、神経筋遮断薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。神経筋遮断薬の種類別市場規模（非分極剤、脱分極剤）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Hikma Pharmaceuticals、Bayer、Merck、GSK、Novartis、AbbVie、Pfizer ・地域別グローバル市場分析 2015年-2020年 ・神経筋遮断薬の北米市場（アメリカ、カナダ、メキシコ） ・神経筋遮断薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・神経筋遮断薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・神経筋遮断薬の南米市場（ブラジル、アルゼンチン） ・神経筋遮断薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：非分極剤、脱分極剤 ・用途別分析：病院薬局、小売薬局、オンライン薬局、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Neuromuscular Blocking Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Neuromuscular Blocking Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Neuromuscular Blocking Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Neuromuscular Blocking Drug market has been segmented into
Non-polarizing Agents
Depolarizing Agents
By Application, Neuromuscular Blocking Drug has been segmented into:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Neuromuscular Blocking Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Neuromuscular Blocking Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Neuromuscular Blocking Drug market.
The report offers in-depth assessment of the growth and other aspects of the Neuromuscular Blocking Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Neuromuscular Blocking Drug Market Share Analysis
Neuromuscular Blocking Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Neuromuscular Blocking Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Neuromuscular Blocking Drug sales, revenue and market share for each player covered in this report.
The major players covered in Neuromuscular Blocking Drug are:
Hikma Pharmaceuticals
Bayer
Merck
GSK
Novartis
AbbVie
Pfizer
Among other players domestic and global, Neuromuscular Blocking Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neuromuscular Blocking Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neuromuscular Blocking Drug, with price, sales, revenue and global market share of Neuromuscular Blocking Drug in 2018 and 2019.
Chapter 3, the Neuromuscular Blocking Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neuromuscular Blocking Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Neuromuscular Blocking Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Neuromuscular Blocking Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Neuromuscular Blocking Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neuromuscular Blocking Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Non-polarizing Agents
1.2.3 Depolarizing Agents
1.3 Market Analysis by Application
1.3.1 Overview: Global Neuromuscular Blocking Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Overview of Global Neuromuscular Blocking Drug Market
1.4.1 Global Neuromuscular Blocking Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Hikma Pharmaceuticals
2.1.1 Hikma Pharmaceuticals Details
2.1.2 Hikma Pharmaceuticals Major Business
2.1.3 Hikma Pharmaceuticals SWOT Analysis
2.1.4 Hikma Pharmaceuticals Product and Services
2.1.5 Hikma Pharmaceuticals Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer SWOT Analysis
2.2.4 Bayer Product and Services
2.2.5 Bayer Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK SWOT Analysis
2.4.4 GSK Product and Services
2.4.5 GSK Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business
2.6.3 AbbVie Product and Services
2.6.4 AbbVie Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Product and Services
2.7.4 Pfizer Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Neuromuscular Blocking Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Neuromuscular Blocking Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Neuromuscular Blocking Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Neuromuscular Blocking Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Neuromuscular Blocking Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Neuromuscular Blocking Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Neuromuscular Blocking Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
4.3 Europe Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
4.5 South America Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Neuromuscular Blocking Drug Sales, Revenue and Market Share by Country
5.1.1 North America Neuromuscular Blocking Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Neuromuscular Blocking Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
5.3 Canada Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Neuromuscular Blocking Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Neuromuscular Blocking Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Neuromuscular Blocking Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
6.3 UK Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
6.4 France Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
6.5 Russia Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
6.6 Italy Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Neuromuscular Blocking Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Neuromuscular Blocking Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Neuromuscular Blocking Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
7.3 Japan Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
7.4 Korea Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
7.5 India Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
7.7 Australia Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Neuromuscular Blocking Drug Sales, Revenue and Market Share by Country
8.1.1 South America Neuromuscular Blocking Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Neuromuscular Blocking Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Neuromuscular Blocking Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Neuromuscular Blocking Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Neuromuscular Blocking Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Neuromuscular Blocking Drug Sales and Market Share by Type (2015-2020)
10.2 Global Neuromuscular Blocking Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Neuromuscular Blocking Drug Price by Type (2015-2020)
11 Global Neuromuscular Blocking Drug Market Segment by Application
11.1 Global Neuromuscular Blocking Drug Sales Market Share by Application (2015-2020)
11.2 Global Neuromuscular Blocking Drug Revenue Market Share by Application (2015-2020)
11.3 Global Neuromuscular Blocking Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Neuromuscular Blocking Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Neuromuscular Blocking Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Neuromuscular Blocking Drug Market Forecast (2021-2025)
12.2.2 Europe Neuromuscular Blocking Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Neuromuscular Blocking Drug Market Forecast (2021-2025)
12.2.4 South America Neuromuscular Blocking Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Neuromuscular Blocking Drug Market Forecast (2021-2025)
12.3 Neuromuscular Blocking Drug Market Forecast by Type (2021-2025)
12.3.1 Global Neuromuscular Blocking Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Neuromuscular Blocking Drug Market Share Forecast by Type (2021-2025)
12.4 Neuromuscular Blocking Drug Market Forecast by Application (2021-2025)
12.4.1 Global Neuromuscular Blocking Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Neuromuscular Blocking Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Neuromuscular Blocking Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Neuromuscular Blocking Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Neuromuscular Blocking Drug Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Neuromuscular Blocking Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Hikma Pharmaceuticals Neuromuscular Blocking Drug Major Business
Table 10. Hikma Pharmaceuticals Neuromuscular Blocking Drug Total Revenue (USD Million) (2018-2019)
Table 11. Hikma Pharmaceuticals SWOT Analysis
Table 12. Hikma Pharmaceuticals Neuromuscular Blocking Drug Product and Services
Table 13. Hikma Pharmaceuticals Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Bayer Basic Information, Manufacturing Base and Competitors
Table 15. Bayer Neuromuscular Blocking Drug Major Business
Table 16. Bayer Neuromuscular Blocking Drug Total Revenue (USD Million) (2018-2019)
Table 17. Bayer SWOT Analysis
Table 18. Bayer Neuromuscular Blocking Drug Product and Services
Table 19. Bayer Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Merck Basic Information, Manufacturing Base and Competitors
Table 21. Merck Neuromuscular Blocking Drug Major Business
Table 22. Merck Neuromuscular Blocking Drug Total Revenue (USD Million) (2018-2019)
Table 23. Merck SWOT Analysis
Table 24. Merck Neuromuscular Blocking Drug Product and Services
Table 25. Merck Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. GSK Basic Information, Manufacturing Base and Competitors
Table 27. GSK Neuromuscular Blocking Drug Major Business
Table 28. GSK Neuromuscular Blocking Drug Total Revenue (USD Million) (2018-2019)
Table 29. GSK SWOT Analysis
Table 30. GSK Neuromuscular Blocking Drug Product and Services
Table 31. GSK Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Novartis Basic Information, Manufacturing Base and Competitors
Table 33. Novartis Neuromuscular Blocking Drug Major Business
Table 34. Novartis Neuromuscular Blocking Drug Total Revenue (USD Million) (2018-2019)
Table 35. Novartis SWOT Analysis
Table 36. Novartis Neuromuscular Blocking Drug Product and Services
Table 37. Novartis Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. AbbVie Basic Information, Manufacturing Base and Competitors
Table 39. AbbVie Neuromuscular Blocking Drug Major Business
Table 40. AbbVie Neuromuscular Blocking Drug Total Revenue (USD Million) (2018-2019)
Table 41. AbbVie SWOT Analysis
Table 42. AbbVie Neuromuscular Blocking Drug Product and Services
Table 43. AbbVie Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Pfizer Basic Information, Manufacturing Base and Competitors
Table 45. Pfizer Neuromuscular Blocking Drug Major Business
Table 46. Pfizer Neuromuscular Blocking Drug Total Revenue (USD Million) (2018-2019)
Table 47. Pfizer SWOT Analysis
Table 48. Pfizer Neuromuscular Blocking Drug Product and Services
Table 49. Pfizer Neuromuscular Blocking Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Global Neuromuscular Blocking Drug Sales by Manufacturer (2018-2019) (K Units)
Table 51. Global Neuromuscular Blocking Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 52. Global Neuromuscular Blocking Drug Sales by Regions (2015-2020) (K Units)
Table 53. Global Neuromuscular Blocking Drug Sales Market Share by Regions (2015-2020)
Table 54. Global Neuromuscular Blocking Drug Revenue by Regions (2015-2020) (USD Million)
Table 55. North America Neuromuscular Blocking Drug Sales by Countries (2015-2020) (K Units)
Table 56. North America Neuromuscular Blocking Drug Sales Market Share by Countries (2015-2020)
Table 57. North America Neuromuscular Blocking Drug Revenue by Countries (2015-2020) (USD Million)
Table 58. North America Neuromuscular Blocking Drug Revenue Market Share by Countries (2015-2020)
Table 59. Europe Neuromuscular Blocking Drug Sales by Countries (2015-2020) (K Units)
Table 60. Europe Neuromuscular Blocking Drug Sales Market Share by Countries (2015-2020)
Table 61. Europe Neuromuscular Blocking Drug Revenue by Countries (2015-2020) (USD Million)
Table 62. Asia-Pacific Neuromuscular Blocking Drug Sales by Regions (2015-2020) (K Units)
Table 63. Asia-Pacific Neuromuscular Blocking Drug Sales Market Share by Regions (2015-2020)
Table 64. Asia-Pacific Neuromuscular Blocking Drug Revenue by Regions (2015-2020) (USD Million)
Table 65. South America Neuromuscular Blocking Drug Sales by Countries (2015-2020) (K Units)
Table 66. South America Neuromuscular Blocking Drug Sales Market Share by Countries (2015-2020)
Table 67. South America Neuromuscular Blocking Drug Revenue by Countries (2015-2020) (USD Million)
Table 68. South America Neuromuscular Blocking Drug Revenue Market Share by Countries (2015-2020)
Table 69. Middle East & Africa Neuromuscular Blocking Drug Sales by Countries (2015-2020) (K Units)
Table 70. Middle East & Africa Neuromuscular Blocking Drug Sales Market Share by Countries (2015-2020)
Table 71. Middle East & Africa Neuromuscular Blocking Drug Revenue by Countries (2015-2020) (USD Million)
Table 72. Middle East & Africa Neuromuscular Blocking Drug Revenue Market Share by Countries (2015-2020)
Table 73. Global Neuromuscular Blocking Drug Sales by Type (2015-2020) (K Units)
Table 74. Global Neuromuscular Blocking Drug Sales Share by Type (2015-2020)
Table 75. Global Neuromuscular Blocking Drug Revenue by Type (2015-2020) (USD Million)
Table 76. Global Neuromuscular Blocking Drug Revenue Share by Type (2015-2020)
Table 77. Global Neuromuscular Blocking Drug Sales by Application (2015-2020) (K Units)
Table 78. Global Neuromuscular Blocking Drug Sales Share by Application (2015-2020)
Table 79. Global Neuromuscular Blocking Drug Sales Forecast by Regions (2021-2025) (K Units)
Table 80. Global Neuromuscular Blocking Drug Market Share Forecast by Regions (2021-2025)
Table 81. Global Neuromuscular Blocking Drug Sales Forecast by Type (2021-2025) (K Units)
Table 82. Global Neuromuscular Blocking Drug Market Share Forecast by Type (2021-2025)
Table 83. Global Neuromuscular Blocking Drug Sales Forecast by Application (2021-2025)
Table 84. Global Neuromuscular Blocking Drug Market Share Forecast by Application (2021-2025)
Table 85. Direct Channel Pros & Cons
Table 86. Indirect Channel Pros & Cons
Table 87. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Neuromuscular Blocking Drug Picture
Figure 2. Global Sales Market Share of Neuromuscular Blocking Drug by Type in 2019
Figure 3. Non-polarizing Agents Picture
Figure 4. Depolarizing Agents Picture
Figure 5. Neuromuscular Blocking Drug Sales Market Share by Application in 2019
Figure 6. Hospital Pharmacy Picture
Figure 7. Retail Pharmacy Picture
Figure 8. Online Pharmacy Picture
Figure 9. Others Picture
Figure 10. Global Neuromuscular Blocking Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Neuromuscular Blocking Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Neuromuscular Blocking Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Neuromuscular Blocking Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Neuromuscular Blocking Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Neuromuscular Blocking Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Neuromuscular Blocking Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Neuromuscular Blocking Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Neuromuscular Blocking Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Neuromuscular Blocking Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Neuromuscular Blocking Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Neuromuscular Blocking Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Neuromuscular Blocking Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Neuromuscular Blocking Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Neuromuscular Blocking Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Neuromuscular Blocking Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Neuromuscular Blocking Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Neuromuscular Blocking Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Neuromuscular Blocking Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Neuromuscular Blocking Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Neuromuscular Blocking Drug Sales Market Share by Manufacturer in 2019
Figure 31. Global Neuromuscular Blocking Drug Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Neuromuscular Blocking Drug Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Neuromuscular Blocking Drug Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Neuromuscular Blocking Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Neuromuscular Blocking Drug Revenue Market Share by Regions (2015-2020)
Figure 38. Global Neuromuscular Blocking Drug Revenue Market Share by Regions in 2018
Figure 39. North America Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
Figure 40. Europe Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
Figure 42. South America Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020)
Figure 44. North America Neuromuscular Blocking Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Neuromuscular Blocking Drug Sales Market Share by Countries (2015-2020)
Figure 46. North America Neuromuscular Blocking Drug Sales Market Share by Countries in 2018
Figure 47. North America Neuromuscular Blocking Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Neuromuscular Blocking Drug Revenue Market Share by Countries in 2018
Figure 49. United States Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Neuromuscular Blocking Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Neuromuscular Blocking Drug Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Neuromuscular Blocking Drug Revenue Market Share by Countries in 2019
Figure 55. Germany Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Neuromuscular Blocking Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Neuromuscular Blocking Drug Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Neuromuscular Blocking Drug Revenue Market Share by Regions 2019
Figure 63. China Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Neuromuscular Blocking Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Neuromuscular Blocking Drug Sales Market Share by Countries in 2019
Figure 70. South America Neuromuscular Blocking Drug Revenue Market Share by Countries in 2019
Figure 71. Brazil Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Neuromuscular Blocking Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Neuromuscular Blocking Drug Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Neuromuscular Blocking Drug Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Neuromuscular Blocking Drug Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Neuromuscular Blocking Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Neuromuscular Blocking Drug Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Neuromuscular Blocking Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Neuromuscular Blocking Drug Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Neuromuscular Blocking Drug Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Neuromuscular Blocking Drug Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Neuromuscular Blocking Drug Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Neuromuscular Blocking Drug Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
急性肝性ポルフィリン症治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Acute Hepatic Porphyria Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…- 抗コリン薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Anticholinergic Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- ノイラミニダーゼ阻害薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Neuraminidase Inhibitors Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 抗マラリア薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-Malarial Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.5% in the forecast period of 2020 to 2025 and will expected to reach USD 774.6 million by 2025, from USD 702.3 million in 2019. The Anti-Malarial Drug …
- 革新的医薬品の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Innovative Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…